AINeutralFortune Crypto · 4h ago6/10
🧠
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
Sanofi is developing proprietary AI tools and workflows instead of purchasing off-the-shelf agentic AI products from SaaS vendors, positioning itself to gain competitive advantages in pharmaceutical development. This strategic shift reflects growing pharmaceutical interest in building custom AI capabilities tailored to specific industry needs rather than relying on generic enterprise solutions.
